Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation.

Boberg E, Kadri N, Winterling J, Davies LC, Björklund A, Msghina M, Iacobaeus E, Le Blanc K.

Haematologica. 2019 Oct 24. pii: haematol.2019.225326. doi: 10.3324/haematol.2019.225326. [Epub ahead of print]

2.

[New national guidelines for the treatment of schizophrenia in Sweden].

von Malortie S, Cronqvist E, Ringbäck G, Flyckt L, Bodlund K, Msghina M, Rosenberg D, Davidson T.

Lakartidningen. 2019 Jan 28;116. pii: FFPU. Swedish.

3.

Health care use, drug treatment and comorbidity in patients with schizophrenia or non-affective psychosis in Sweden: a cross-sectional study.

Brostedt EM, Msghina M, Persson M, Wettermark B.

BMC Psychiatry. 2017 Dec 29;17(1):416. doi: 10.1186/s12888-017-1582-x.

4.

Studying Sub-Dendrograms of Resting-State Functional Networks with Voxel-Wise Hierarchical Clustering.

Wang Y, Msghina M, Li TQ.

Front Hum Neurosci. 2016 Mar 8;10:75. doi: 10.3389/fnhum.2016.00075. eCollection 2016.

5.

[Participation is the foundation of successful treatment of psychotic disorders].

Flyckt L, Msghina M.

Lakartidningen. 2015 Oct 13;112. pii: DDZA. Review. Swedish.

6.

Differential Effects of Single-Dose Escitalopram on Cognitive and Affective Interference during Stroop Task.

Rahm C, Liberg B, Kristoffersen-Wiberg M, Aspelin P, Msghina M.

Front Psychiatry. 2014 Feb 25;5:21. doi: 10.3389/fpsyt.2014.00021. eCollection 2014.

7.

Rostro-caudal and dorso-ventral gradients in medial and lateral prefrontal cortex during cognitive control of affective and cognitive interference.

Rahm C, Liberg B, Wiberg-Kristoffersen M, Aspelin P, Msghina M.

Scand J Psychol. 2013 Apr;54(2):66-71. doi: 10.1111/sjop.12023. Epub 2013 Jan 15.

PMID:
23316801
8.

[Benefits and risks of benzodiazepines. A current analysis of facts].

Allgulander C, Msghina M.

Lakartidningen. 2011 Oct 12-18;108(41):2025-9. Review. Swedish. No abstract available.

PMID:
22111250
9.

[Schizophrenia, neurodegeneration and antipsychotic agents].

Msghina M, Liberg B.

Lakartidningen. 2009 Nov 18-24;106(47):3183; discussion 3183. Swedish. No abstract available.

PMID:
20077648
10.

[Antipsychotic agents are best chosen by their adverse effect profile].

Msghina M, Lindefors N.

Lakartidningen. 2009 Oct 28-Nov 3;106(44):2841-2, 2844-6. Review. Swedish. No abstract available.

PMID:
19967963
11.

Crustacean frequenins: molecular cloning and differential localization at neuromuscular junctions.

Jeromin A, Shayan AJ, Msghina M, Roder J, Atwood HL.

J Neurobiol. 1999 Nov 5;41(2):165-75.

PMID:
10512975
12.

Calcium entry related to active zones and differences in transmitter release at phasic and tonic synapses.

Msghina M, Millar AG, Charlton MP, Govind CK, Atwood HL.

J Neurosci. 1999 Oct 1;19(19):8419-34.

13.
14.
16.

Synaptic structure and transmitter release in crustacean phasic and tonic motor neurons.

Msghina M, Govind CK, Atwood HL.

J Neurosci. 1998 Feb 15;18(4):1374-82.

17.

Differential physiology and morphology of phasic and tonic motor axons in a crayfish limb extensor muscle

Bradacs H, Cooper R, Msghina M, Atwood H.

J Exp Biol. 1997;200(Pt 4):677-91.

18.

Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo.

Suaud-Chagny MF, Dugast C, Chergui K, Msghina M, Gonon F.

J Neurochem. 1995 Dec;65(6):2603-11.

PMID:
7595557
21.

Spatiotemporal pattern of quantal release of ATP and noradrenaline from sympathetic nerves: consequences for neuromuscular transmission.

Stjärne L, Astrand P, Bao JX, Gonon F, Msghina M, Stjärne E.

Adv Second Messenger Phosphoprotein Res. 1994;29:461-96. Review.

PMID:
7848726
23.

Kinetics of noradrenaline released by sympathetic nerves.

Gonon F, Msghina M, Stjärne L.

Neuroscience. 1993 Oct;56(3):535-8.

PMID:
8255421
25.

Fast and local electrochemical monitoring of noradrenaline release from sympathetic terminals in isolated rat tail artery.

Gonon F, Bao JX, Msghina M, Suaud-Chagny MF, Stjärne L.

J Neurochem. 1993 Apr;60(4):1251-7.

PMID:
8455024
27.

On the geometry, kinetics and plasticity of sympathetic neuromuscular transmission.

Stjärne L, Bao JX, Gonon F, Msghina M, Stjärne E.

Jpn J Pharmacol. 1992;58 Suppl 2:158P-165P. Review. No abstract available.

28.
29.
30.

K+ and Ca2+ channel blocking agents increase or decrease stimulus-evoked but not spontaneous quantal transmitter release in sympathetic nerve terminals.

Stjärne L, Msghina M, Stjärne E.

Acta Physiol Scand. 1990 Feb;138(2):235-7. No abstract available.

PMID:
2156406
31.

Evidence that action potential-induced Ca2+ influx is necessary but not sufficient to release transmitter from sympathetic nerve terminals.

Msghina M, Stjärne E, Astrand P, Stjärne L.

Acta Physiol Scand. 1990 Feb;138(2):239-40. No abstract available.

PMID:
1969221
32.

"Upstream" regulation of the release probability in sympathetic nerve varicosities.

Stjärne L, Msghina M, Stjärne E.

Neuroscience. 1990;36(3):571-87. Review.

PMID:
1978258
33.

Presynaptic receptors and modulation of noradrenaline and ATP secretion from sympathetic nerve varicosities.

Stjärne L, Bao JX, Gonon FG, Mermet C, Msghina M, Stjärne E, Astrand P.

Ann N Y Acad Sci. 1990;604:250-65.

PMID:
1977352
34.
35.

Is 'upstream' control of sympathetic transmitter release dependent on the length of varicosity strings?

Stjärne L, Msghina M, Stjärne E.

Acta Physiol Scand. 1989 Oct;137(2):313-4. No abstract available.

PMID:
2575844
36.

Temperature dependence of 'local' and 'upstream' regulation of sympathetic transmitter secretion in mouse vas deferens.

Stjärne L, Msghina M, Stjärne E, Tanaka E.

Acta Physiol Scand. 1989 Oct;137(2):311-2. No abstract available.

PMID:
2575843
37.

K+ channel-blocking agents may augment sympathetic transmitter secretion by action 'upstream' of varicosities.

Stjärne L, Msghina M, Stjärne E.

Acta Physiol Scand. 1989 Sep;137(1):151-2. No abstract available.

PMID:
2801154
38.

Is cyclic AMP the intra-axonal messenger 'X' mediating 'upstream' control of sympathetic transmitter secretion?

Stjärne L, Msghina M, Stjärne E.

Acta Physiol Scand. 1989 Aug;136(4):617-8. No abstract available.

PMID:
2571237
39.

Cd2+ may inhibit ATP secretion from sympathetic nerves in rat tail artery by an 'upstream' effect without blocking the Ca2+ component of the action potential in the terminals.

Stjärne L, Msghina M, Stjärne E, Astrand P.

Acta Physiol Scand. 1989 Jun;136(2):299-300. No abstract available.

PMID:
2782100
40.

Does clonidine- or neuropeptide Y-mediated inhibition of ATP secretion from sympathetic nerves operate primarily by increasing a potassium conductance?

Stjärne L, Stjärne E, Msghina M.

Acta Physiol Scand. 1989 May;136(1):137-8. No abstract available.

PMID:
2773656
41.

Potassium channel blocking agents induce occasional spontaneous action potentials and multiquantal ATP release in sympathetic nerve terminals.

Msghina M, Stjärne E, Stjärne L.

Acta Physiol Scand. 1989 Apr;135(4):593-4. No abstract available.

PMID:
2544080
42.

Do alpha 2-agonists inhibit sympathetic transmitter secretion in part by depressing a Ca2+ component of the nerve impulse 'upstream' of varicosities?

Stjärne C, Stjärne E, Msghina M.

Acta Physiol Scand. 1988 Aug;133(4):591-2. No abstract available.

PMID:
2906514

Supplemental Content

Loading ...
Support Center